Related Experiment Video
Updated: Dec 28, 2025

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches
Etienne Empweb Anger1, Feng Yu1, Ji Li1
1Department of Clinical Pharmacy, School of Basic Medical Sciences and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Aristolochic acid (AA) from Aristolochiaceae plants causes kidney damage and urothelial carcinoma. This review details AA
Area of Science:
- Toxicology
- Molecular Biology
- Carcinogenesis
Background:
- Aristolochic acid (AA) from Aristolochiaceae plants is linked to nephropathy and upper urothelial carcinoma (UUC).
- The precise mechanisms of AA-induced toxicity and carcinogenesis remain incompletely understood.
- Current therapeutic strategies for AA-related pathologies are limited due to incomplete mechanistic knowledge.
Purpose of the Study:
- To review the molecular mechanisms of AA-induced nephrotoxicity, focusing on enzymatic bioactivation.
- To discuss agents and strategies for mitigating AA-induced nephrotoxicity.
- To provide an updated overview of AA nephrotoxicity, incorporating recent findings and suggesting future research directions.
Main Methods:
- Literature review of studies on AA nephrotoxicity and carcinogenesis.
- Analysis of molecular mechanisms, including enzymatic bioactivation pathways.
- Synthesis of information on protective agents and their modes of action.
Main Results:
- AA undergoes enzymatic bioactivation to reactive metabolites that induce cellular damage.
- Specific molecular pathways involved in AA-induced kidney toxicity and urothelial cancer are detailed.
- Various agents show potential in reducing AA nephrotoxicity through different mechanisms.
Conclusions:
- Understanding AA's bioactivation is crucial for elucidating its nephrotoxic and carcinogenic effects.
- Identifying and developing protective agents can offer therapeutic avenues.
- Further research is needed to fully elucidate AA mechanisms and optimize protective strategies.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Antihypertensive Drugs: Direct Renin Inhibitors